A New Use for an Old Treatment: Radiation Therapy and Alzheimer's Disease

被引:11
|
作者
Wilson, George D. [1 ]
Marples, Brian [1 ]
机构
[1] William Beaumont Hosp, Dept Radiat Oncol, 3811 W Thirteen Mile Rd,105-RI, Royal Oak, MI 48073 USA
关键词
TERM NEUROCOGNITIVE OUTCOMES; ACUTE LYMPHOBLASTIC-LEUKEMIA; APOE PROMOTER POLYMORPHISMS; GENOME-WIDE ASSOCIATION; CRANIAL TRANSPLANTATION; COGNITIVE IMPAIRMENT; IDENTIFIES VARIANTS; APOLIPOPROTEIN-E; MOUSE MODELS; BRAIN;
D O I
10.1667/RR14367.1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
With the incidence of Alzheimer's disease anticipated to triple in the next few decades, it is critical to establish more successful novel treatments or preventive measures that reduce disease progression. Radiation therapy has not been previously used or considered as a potential treatment for AD pathologies and our observations provide intriguing data that merit further investigation. Although caution is warranted, overall the data support a beneficial effect of low-dose radiation treatment for AD pathologies in a widely used AD murine model. Radiation therapy is a well established and safe medical modality defined by decades of clinical application. Moreover, radiation therapy as a treatment approach for AD could be implemented quickly and inexpensively, given the prevalence of radiotherapy centers across the U.S. Additionally, the use of radiation therapy for AD is suitable to all patients with mild or severe AD symptoms. © 2016 by Radiation Research Society.
引用
收藏
页码:443 / 448
页数:6
相关论文
共 50 条
  • [41] New hope for the diagnosis and therapy of Alzheimer's disease
    Kastenholz, Bernd
    PROTEIN AND PEPTIDE LETTERS, 2007, 14 (04): : 389 - 393
  • [42] Statin use and risk of Alzheimer disease: A new view on an old relationship
    Yasar, Sevil
    Whitmer, Rachel
    NEUROLOGY, 2018, 90 (03) : 103 - 104
  • [43] Filling the void for new Alzheimer's disease therapy
    不详
    NATURE AGING, 2021, 1 (07): : 567 - 568
  • [44] Filling the void for new Alzheimer’s disease therapy
    Nature Aging, 2021, 1 : 567 - 568
  • [45] Adjunctive use of amisulpride on acetylcholine inhibitors therapy for the treatment of psychotic symptoms in Alzheimer's disease
    Theleritis, C.
    Politis, A.
    Passa, M.
    Lentidaki, F.
    Stamouli, E.
    Maillis, A.
    Papadimitriou, G. N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S622 - S622
  • [46] Can We Teach Old Dogs New Tricks? Neuroprotective Cell Therapy in Alzheimer's and Parkinson's Disease
    Kazmerova, Zuzana
    Zilka, Norbert
    Cente, Martin
    Neradil, Peter
    Zilkova, Monika
    Novak, Michal
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 37 (02) : 251 - 272
  • [47] The use of cavinton and cerebrolysin in the preventive therapy of Alzheimer's disease
    Kasatkin, D. S.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (10) : 85 - 86
  • [48] Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
    Benzi, G
    Moretti, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 346 (01) : 1 - 13
  • [49] TREATMENT PARAMETERS AND RATIONALE FOR THE USE OF ELECTROCONVULSIVE THERAPY FOR THE MANAGEMENT OF TREATMENT-REFRACTORY AGITATION IN ALZHEIMER'S DISEASE
    Hermida, Adriana P.
    Petrides, Georgios
    Lapid, Maria
    Nykamp, Louis
    Chapman, Hannah
    McDonald, William
    Riva-Posse, Patricio
    Lunceford, Autumn
    Sanghani, Sohag
    Seiner, Steve
    Harper, David
    Rahman, Aniqa
    Kilpatrick, Emily
    Sutor, Bruce
    Johnson, Emily
    Walton, Monica
    Mueller, Martina
    Knapp, Rebecca
    Dillon, Catherine
    Forester, Brent
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S144 - S145
  • [50] MicroRNAs as a New Target for Alzheimer's Disease Treatment
    Shademan, Behrouz
    Avci, Cigir Biray
    Karamad, Vahidreza
    Sogutlu, Fatma
    Nourazarian, Alireza
    MICRORNA, 2023, 12 (01) : 3 - 12